Acute lymphoblastic leukaemia: open trials in Ireland

• NCT05327894

  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology

  Children's Health Ireland, Dublin

  Registry updated 2026-10-19

• NCT04307576

  A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

  Trial Treatment · Phase 3 · Mats Heyman

  Cork University Hospital, Cork · Children's Health Ireland, Dublin · St James's Hospital, Dublin 8 · University Hospital Galway, Galway

  Registry updated 2026-08-12

• 2023-504694-20-00

  Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  Children's Health Ireland, Dublin

  Registry updated 2026-06-04

• NCT05658640

  HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Our Lady's Hospital for Sick Children, Dublin

  Registry updated 2025-09-16

• NCT05745714

  HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Our Lady's Hospital for Sick Children, Dublin

  Registry updated 2025-09-16

• NCT05751044

  HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Our Lady's Hospital for Sick Children, Dublin

  Registry updated 2025-09-16

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error